[Federal Register Volume 81, Number 55 (Tuesday, March 22, 2016)]
[Proposed Rules]
[Pages 15217-15219]
[FR Doc No: 2016-06391]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2016-0050]

49 CFR Parts 393 and 395

Hours of Service of Drivers; Parts and Accessories: ArcelorMittal
Indiana Harbor, LLC, Application for Exemptions

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of application for exemptions; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces that it has received an application from
ArcelorMittal Indiana Harbor, LLC (ArcelorMittal) requesting exemptions
for our regulations. The first exemption request is for ArcelorMittal's
employee-drivers with commercial driver's licenses (CDLs) who transport
steel coils between their production and shipping locations on public
roads. ArcelorMittal requests this exemption to allow its employee-
drivers to work up to 16 hours per day and be allowed to return to work
with less than the mandatory 10 consecutive hours off duty.
ArcelorMittal also requests exemptions in parts of our regulations for
its coil carriers that do not meet all of the vehicle requirements in
sections of our regulations. FMCSA requests public comment on
ArcelorMittal's application for exemptions.

DATES: Comments must be received on or before April 21, 2016.

ADDRESSES: You may submit comments identified by Federal Docket
Management System Number FMCSA-2016-0050 by any of the following
methods:
     Federal eRulemaking Portal: www.regulations.gov. Follow
the online instructions for submitting comments.
     Mail: Docket Management Facility, U.S. Department of
Transportation, 1200 New Jersey Avenue SE., West Building, Ground
Floor, Room W12-140, Washington, DC 20590-0001.
     Hand Delivery or Courier: West Building, Ground Floor,
Room W12-140, 1200 New Jersey Avenue SE., between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal holidays.
     Fax: 1-202-493-2251.
    Instructions: All submissions must include the Agency name and
docket number. For detailed instructions on submitting comments and
additional information on the exemption process, see the Public
Participation heading below. Note that all comments received will be
posted without change to www.regulations.gov, including any personal
information provided. Please see the Privacy Act heading below.
    Docket: For access to the docket to read background documents or
comments received, go to www.regulations.gov, and follow the online
instructions for accessing the dockets, or go to the street address
listed above.
    Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits
comments from the public to better inform its rulemaking process. DOT
posts these comments, without edit, including any personal information
the commenter provides, to www.regulations.gov, as described in the
system of records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.dot.gov/privacy.
    Public participation: The Federal eRulemaking Portal is available
24 hours each day, 365 days each year. You can obtain electronic
submission and retrieval help and guidelines under the ``help'' section
of the Federal eRulemaking Portal Web site. If you want us to notify
you that we received your comments, please include a self-addressed,
stamped envelope or postcard, or print the acknowledgement page that
appears after submitting comments online.

FOR FURTHER INFORMATION CONTACT: Ms. Pearlie Robinson, FMCSA Driver and
Carrier Operations Division; Office of Carrier, Driver and Vehicle
Safety Standards; Telephone:<PHONE_NUMBER>. Email<EMAIL_ADDRESS>If you
have questions on viewing or submitting material to the docket, contact
Docket Services, telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Public Participation and Request for Comments

    FMCSA encourages you to participate by submitting comments and
related materials.

Submitting Comments

    If you submit a comment, please include the docket number for this
notice (FMCSA-2016-0050), indicate the specific section of this
document to which the comment applies, and provide a reason for
suggestions or recommendations. You may submit your comments and
material online or by fax, mail, or hand delivery, but please use only
one of these means. FMCSA recommends that you include your name and a
mailing address, an email address, or a phone number in the body of
your document so the Agency can contact you if it has questions
regarding your submission.
    To submit your comment online, go to www.regulations.gov and put
the docket number, ``FMCSA-2016-0050'' in the ``Keyword'' box, and
click ``Search.'' When the new screen appears, click on ``Comment
Now!'' button and type your comment into the text box in the following
screen. Choose whether you are submitting your comment as an individual
or on behalf of a third party and then submit. If you submit your
comments by mail or hand delivery, submit them in an unbound format, no
larger than 8\1/2\ by 11 inches, suitable for copying and electronic
filing. If you submit comments by mail and would like to know that they
reached the facility, please enclose a stamped, self-addressed postcard
or envelope. FMCSA will consider all comments and material received
during the comment period and may grant or not grant this application
based on your comments.

Viewing Comments and Documents

    To view comments, as well as documents mentioned in this preamble
as being available in the docket, go to www.regulations.gov and insert
the docket number, ``FMCSA-2016-0050'' in the ``Keyword'' box and click
``Search.'' Next, click ``Open Docket Folder'' button and choose the
document listed to review. If you do not have access to the Internet,
you may view the docket online by visiting the Docket Management
Facility in Room W12-140 on the ground floor of the DOT West Building,
1200 New Jersey Avenue SE., Washington, DC 20590, between 9 a.m. and 5
p.m., e.t., Monday through Friday, except Federal holidays.

II. Legal Basis

    FMCSA has authority under 49 U.S.C. 31136(e) and 31315 to grant
exemptions from certain parts of the Federal Motor Carrier Safety
Regulations. FMCSA must publish a notice of each exemption request in
the Federal Register (49 CFR 381.315(a)). The Agency must provide

the public an opportunity to inspect the information relevant to the
application, including any safety analyses that have been conducted.
The Agency must also provide an opportunity for public comment on the
request.
    The Agency reviews safety analyses and public comments submitted,
and determines whether granting the exemption would likely achieve a
level of safety equivalent to, or greater than, the level that would be
achieved by the current regulation (49 CFR 381.305). The decision of
the Agency must be published in the Federal Register (49 CFR
381.315(b)) with the reasons for denying or granting the application
and, if granted, the name of the person or class of persons receiving
the exemption, and the regulatory provision from which the exemption is
granted. The notice must also specify the effective period and explain
the terms and conditions of the exemption. The exemption may be renewed
(49 CFR 381.300(b)).

III. Request for Exemption

    Under 49 CFR 395.3(a)(2), a property-carrying commercial motor
vehicle (CMV) driver is prohibited from operating a CMV after having
been on duty for 14 consecutive hours following 10 or more consecutive
hours off duty. Once an individual has reached the end of this 14
consecutive-hour period, he or she cannot drive a CMV again without
taking a minimum of 10 consecutive hours off duty.
    ArcelorMittal (USDOT 1098829) operates a steel plant that is
located in East Chicago, Indiana, its principal place of business. The
plant currently encompasses an area which has several public roadways
that run through its present location. Steel coils produced in one
portion of the plant require driver-employees to travel on public
roadways at two points to move the coils to another portion of the
plant for further processing or for shipment to customers. Both points
are controlled intersections, having either traffic lights or a
combination of traffic lights and signs in the area, where the vehicles
cross. The first public road the CMVs cross is Riley Road. The crossing
is controlled by a traffic signal in both directions. The distance
traveled at this crossing is 80 feet in length. The average number of
crossings at this intersection is 24 per day. The second crossing is at
Dickey Road and 129th Street. The distance traveled at this crossing is
.2 miles. The trucks cross 129th Street 24 times per day.
    All employee-drivers are required to hold CDLs and adhere to the
regulations that apply to CMV drivers. Specialized equipment and
trailers are used to move steel coils due to the size of the coils. The
tractors maximum speed is 30-35 miles per hour, but when moving a fully
loaded trailer the maximum speed is 15 miles per hour.
    Trailer beds are configured in such a way as create a cradle to
hold the steel coils in place on the bed of the trailer. The trailers
have a bed height of 68 inches, and bed width of 114 inches. The
trailers maximum height is 14 feet.
    The tractors and trailer in combination unloaded have a gross
combination weight of 77,000 pounds. When fully loaded the gross
combination vehicle weight is 263,171 pounds. Additionally, the
trailers have off-road tires. These types of tires are necessary to
operate both inside and outside the plant safely, given the type of
roadway surface inside the plant area and the weight of the loads.
These vehicles have many of the same features of a typical tractor and
trailer, but do not meet all of the parts and accessories requirements
in 49 CFR part 393.
    When employee-drivers move these vehicles, they are fully marked as
an ``oversize load'' and have flags on the front of the tractor. The
driving of these vehicles amounts to 10 percent of the employee-drivers
total work day. ArcelorMittal contends that none of these employee-
drivers work more than 16 hours per day and advises that a 16-hour work
day is the exception, not the rule.
    According to ArcelorMittal, the current hours-of-service (HOS)
regulations create problems for employee-drivers as these employees
typically work an 8-hour shift plus overtime while employees in the
production and shipping areas work 12-hour shifts. Employee-drivers
must go home under the current arrangement leaving a 4-hour gap between
production and the driver's schedule, creating a possible shortage of
coils for shipping or processing. ArcelorMittal asserts that the
limited amount of employees used to drive the CMVs make it difficult to
schedule when the vehicles move. ArcelorMittal anticipates only 3 of
the 24 crossings at each noted intersection would occur after the 14th
hour on-duty.
    ArcelorMittal requests an exemption from 49 CFR part 395 for its
employee-drivers. Under a waiver of the HOS regulations, employee-
drivers would be able to follow the same schedule as the employees in
the production and shipping areas. ArcelorMittal could then minimize
the chances of possible shortages of coils for shipping or processing.
ArcelorMittal advises that it would ensure all employee-drivers would
not work more than 16 hours per shift, would receive 8 hours off duty
between shifts, and would not be allowed to drive more than 10 percent
of their total work day.
    ArcelorMittal also requests exemptions for its coil carriers from
certain sections in 49 CFR part 393 as follows: The heavy hauler
trailer definition in Sec.  393.5; the height of rear side marker
lights in Sec.  393.11 Table 1--Footnote 4; the tire loading
restrictions in Sec.  393.75(f); and the coil securement requirements
in Sec.  393.120. As previously noted, the vehicles used to transport
steel coils have many of the same features of a typical tractor and
trailer, but do not meet all of the parts and accessories requirements
in 49 CFR part 393.
    According to ArcelorMittal, its equipment was designed for in-
facility use and very limited road use. Public roadways are crossed due
to operational necessity. ArcelorMittal advises that they have never
had an issue at the crossings mentioned with their equipment or
drivers. The coils are well-secured in the vehicles with the cradle
design of their trailers. The time it would take to secure the coils
per the regulations would be longer than the transit time it takes to
move the coils from part of the plant to another.
    ArcelorMittal asserts that it has taken additional precautions to
make sure the public roadway crossings are at the shortest points and
only at controlled intersections. ArcelorMittal ensures all lights are
properly working on both the tractor and trailer. They also flag and
mark the vehicles as ``oversize'' loads. Trailers have conspicuity tape
down the entire side to make them more visible to other traffic.
ArcelorMittal believes that the additional precautions ensure a level
of safety that is equivalent to or exceeds the level of safety achieved
by following the regulations.
    ArcelorMittal acknowledges in its application that these drivers
would still be subject to all of the other applicable Federal
regulations. This includes qualification of drivers, controlled
substance and alcohol testing and inspection, and maintenance and
repair of vehicles.
    Included in ArcelorMittal's application are illustrations of the
plant's location, public roads crossed, and pictures of the tractors
and trailers used to transport the steel coils. A copy of
ArcelorMittal's application for the exemptions is available for review
in the docket for this notice.

    Issued on: March 16, 2016.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2016-06391 Filed 3-21-16; 8:45 am]
BILLING CODE 4910-EX-P


[Federal Register Volume 79, Number 204 (Wednesday, October 22, 2014)]
[Notices]
[Pages 63129-63130]
[FR Doc No: 2014-25048]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-D-1540]

Migraine: Developing Drugs for Acute Treatment; Draft Guidance
for Industry; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of a draft guidance for industry entitled ``Migraine:
Developing Drugs for Acute Treatment.'' The purpose of this guidance is
to assist sponsors in the clinical development of drugs for the acute
treatment of migraine. This guidance focuses on specific drug
development and trial design issues that are unique to the study of
drugs for the acute treatment of migraine. This guidance is intended to
serve as a focus for continued discussions among the Division of
Neurology Products, pharmaceutical sponsors, the academic community,
and the public.

DATES: Although you can comment on any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency considers your comment on this
draft guidance before it begins work on the final version of the
guidance, submit either electronic or written comments on the draft
guidance by December 22, 2014.

ADDRESSES: Submit written requests for single copies of the draft
guidance to the Division of Drug Information, Center for Drug
Evaluation and Research, Food and Drug Administration, 10001 New
Hampshire Ave., Hillandale Building, 4th Floor, Silver Spring, MD
20993. Send one self-addressed adhesive label to assist that office in
processing your requests. See the SUPPLEMENTARY INFORMATION section for
electronic access to the draft guidance document.
    Submit electronic comments on the draft guidance to http://www.regulations.gov. Submit written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Eric Bastings, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 22, Rm. 4338, Silver Spring, MD 20993-0002, 301-
796-1039.

SUPPLEMENTARY INFORMATION:

I. Background

    FDA is announcing the availability of a draft guidance for industry
entitled ``Migraine: Developing Drugs for Acute Treatment.'' The
purpose of this guidance is to assist sponsors in the clinical
development of drugs for the acute treatment of migraine. This guidance
focuses on specific drug development and trial design issues that are
unique to the study of drugs for the acute treatment of migraine. This
guidance is intended to serve as a focus for continued discussions
among the Division of Neurology Products, pharmaceutical sponsors, the
academic community, and the public.
    Migraine is a chronic neurovascular disorder characterized by
recurrent attacks of often severe headache, typically presenting with
nausea, vomiting, and sensitivity to light and/or sound. Pharmacologic
approaches to the treatment of migraine include drugs to treat acute
migraine attacks as they arise (acute treatment of migraine) and drugs
to reduce the frequency of migraine attacks (preventive treatment).
This guidance addresses the development program of drugs for the acute
treatment of migraine, including trial population, trial design, dose
selection, efficacy endpoints, and statistical considerations. The
guidance also discusses safety considerations, pediatric studies, and
labeling considerations.
    This draft guidance is being issued consistent with FDA's good
guidance practices regulation (21 CFR 10.115). The draft guidance, when
finalized, will represent the Agency's current thinking on developing
drugs for the acute treatment of migraine. It does not create or confer
any rights for or on any person and does not operate to bind FDA or the
public. An alternative approach may be used if such approach satisfies
the requirements of the applicable statutes and regulations.

II. The Paperwork Reduction Act of 1995

    This guidance refers to previously approved collections of
information that are subject to review by the Office of Management and
Budget (OMB) under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-
3520). The collections of information in 21 CFR parts 201, 312, and 314
have been approved under OMB control numbers 0910-0572, 0910-0014, and
0910-0001, respectively.

III. Comments

    Interested persons may submit either electronic comments regarding
this document to http://www.regulations.gov or written comments to the
Division of Dockets Management (see ADDRESSES). It is only necessary to
send one set of comments. Identify comments with the

docket number found in brackets in the heading of this document.
Received comments may be seen in the Division of Dockets Management
between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to
the docket at http://www.regulations.gov.

IV. Electronic Access

    Persons with access to the Internet may obtain the document at
either http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm or http://www.regulations.gov.

    Dated: October 15, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-25048 Filed 10-21-14; 8:45 am]
BILLING CODE 4164-01-P